Journal of Clinical Oncology, Vol 9, 400-405, Copyright © 1991 by American Society of Clinical Oncology
Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia
EA Schriock, MJ Schell, M Carter, O Hustu and JJ Ochs
Department of Pediatrics, University of Tennessee, Memphis.
Significant growth retardation was found in 115 survivors of childhood
acute lymphoblastic leukemia (ALL) who had completed their growth. These
children were diagnosed before 12 years of age and treated on four
protocols in a single institution; all received either cranial (n = 78) or
craniospinal (n = 37) prophylactic irradiation. Patients' heights at
diagnosis were within expected ranges, but final heights were greater than
or equal to 1 SD below population means in 74% of cases and greater than or
equal to 2 SD in 37%. Effects on growth were more pronounced for children
who had received craniospinal irradiation, but decrements were also
significant in the cranial irradiation group, with adult heights greater
than or equal to 2 SD below population norms in 32%. Growth retardation was
significantly greater (P less than .0001) in children who had earlier
disease onset. Growth deceleration occurred not only during chemotherapy
but during a later period that followed an interval of improved growth in
many cases. Thus, late decrements in growth may be missed in studies that
do not follow patients until they have attained final heights. These
findings indicate that abnormally short stature among survivors of ALL
merits further clinical and research attention.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Burkhardt, W. Woessmann, M. Zimmermann, U. Kontny, J. Vormoor, W. Doerffel, G. Mann, G. Henze, F. Niggli, W.-D. Ludwig, et al.
Impact of Cranial Radiotherapy on Central Nervous System Prophylaxis in Children and Adolescents With Central Nervous System-Negative Stage III or IV Lymphoblastic Lymphoma
J. Clin. Oncol.,
January 20, 2006;
24(3):
491 - 499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Lerner, G. J. M. Huang, D. McMahon, C. A. Sklar, and S. E. Oberfield
Growth Hormone Therapy in Children after Cranial/Craniospinal Radiation Therapy: Sexually Dimorphic Outcomes
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
6100 - 6104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Oeffinger and M. M. Hudson
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
CA Cancer J Clin,
July 1, 2004;
54(4):
208 - 236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Xu, A. Janss, R. J. Packer, P. Phillips, J. Goldwein, and T. Moshang Jr.
Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy
Neuro-oncol,
April 1, 2004;
6(2):
113 - 118.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Dalton, M. Rue, L. B. Silverman, R. D. Gelber, B. L. Asselin, R. D. Barr, L. A. Clavell, C. A. Hurwitz, A. Moghrabi, Y. Samson, et al.
Height and Weight in Children Treated for Acute Lymphoblastic Leukemia: Relationship to CNS Treatment
J. Clin. Oncol.,
August 1, 2003;
21(15):
2953 - 2960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Leung, S. R. Rose, Y. Zhou, M. L. Hancock, S. Burstein, E. A. Schriock, R. Lustig, R. K. Danish, W. E. Evans, M. M. Hudson, et al.
Outcomes of Growth Hormone Replacement Therapy in Survivors of Childhood Acute Lymphoblastic Leukemia
J. Clin. Oncol.,
July 1, 2002;
20(13):
2959 - 2964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Diagnosis of Hidden Central Hypothyroidism in Survivors of Childhood Cancer
J. Clin. Endocrinol. Metab.,
December 1, 1999;
84(12):
4472 - 4479.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F Craig, A D Leiper, R Stanhope, C Brain, S T Meller, and S S Nussey
Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index
Arch. Dis. Child.,
December 1, 1999;
81(6):
500 - 504.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Robson
Bone growth mechanisms and the effects of cytotoxic drugs
Arch. Dis. Child.,
October 1, 1999;
81(4):
360 - 364.
[Full Text]
|
 |
|

|
 |

|
 |
 
N H Birkebæk and N Clausen
Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia
Arch. Dis. Child.,
August 1, 1998;
79(2):
161 - 164.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S.-C. J. Yeung, A. C. Chiu, R. Vassilopoulou-Sellin, and R. F. Gagel
The Endocrine Effects of Nonhormonal Antineoplastic Therapy
Endocr. Rev.,
April 1, 1998;
19(2):
144 - 172.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Burstein
Consultation with the Specialist: Poor Growth After Cranial Irradiation
Pediatr. Rev.,
December 1, 1997;
18(12):
442 - 444.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. M. Moore
Central Nervous System Toxicity of Cancer Therapy in Children
Journal of Pediatric Oncology Nursing,
January 1, 1995;
12(4):
203 - 210.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. K. Rivera, D. Pinkel, J. V. Simone, M. L. Hancock, and W. M. Crist
Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital
N. Engl. J. Med.,
October 28, 1993;
329(18):
1289 - 1295.
[Abstract]
[Full Text]
|
 |
|
|